Vall d’Hebron study finds strong agreement between microscopy and Techcyte AI for stool parasite testing

Techcyte said a peer-reviewed study from Vall d’Hebron University Hospital in Barcelona found high agreement between conventional microscopy and its AI-assisted system for fecal ova and parasite testing. The results suggest AI can help technologists surface more potential findings for expert review in a highly manual lab workflow.

Why it matters: - Ova and parasite testing is labor-intensive and depends heavily on technologist attention and experience. - The findings suggest AI-assisted microscopy can help labs flag more potential parasite findings for expert review. - Techcyte positioned the technology as a screening aid, not a replacement for trained interpretation.

What happened: - Techcyte announced publication of a peer-reviewed study in the Journal of Clinical Microbiology evaluating its fecal ova and parasite detection Wet Mount Iodine solution for stool specimens. - Researchers at the International Health Unit of the Microbiology Department of Vall d’Hebron University Hospital in Barcelona, Spain, conducted the retrospective study with associated institutions. - The study compared conventional microscopy with Techcyte’s AI-assisted system plus operator review. - The study evaluated 178 clinical stool specimens.

The details: - Techcyte’s AI-assisted system achieved 96.62% positive agreement and 93.33% negative agreement versus conventional microscopy when combined with operator review. - AI-assisted review surfaced additional parasite findings in 74 of 178 specimens. - That represented more than 40% of the specimens evaluated. - Carles Rubio, a post-doctoral researcher in Vall d’Hebron’s International Health Unit of Microbiology, said AI-assisted microscopy can be a valuable screening tool for finding parasites in low-burden stool while preserving expert review in the final interpretation. - Vijetha Kumar, product manager for parasitology at Techcyte, said the company sees AI as support for trained professionals rather than a replacement. - The full study is titled “Performance of the Techcyte AI-based image analysis system for coproparasitological diagnosis in clinical stool specimens: a retrospective evaluation study.” - Techcyte’s AI-assisted microscopy solutions are distributed in Spain by Grifols, which supported the collaboration with Vall d’Hebron.

Between the lines: - The study points to a practical use case for AI in pathology: improving the first-pass review process without removing the human expert from the final decision. - The additional findings in more than 40% of specimens suggest AI may help reduce the chance that low-burden structures are overlooked. - The result also fits Techcyte’s broader pitch for AI-assisted pathology as a workflow tool rather than a diagnostic substitute.

What's next: - Techcyte will likely use the publication to support adoption of its AI-assisted parasitology workflow in clinical labs. - The collaboration with Vall d’Hebron and Grifols may help advance additional evaluations or deployments in Spain. - Techcyte says its broader pathology platform is aimed at digitizing lab workflows and improving testing efficiency and accuracy.

The bottom line: - The Vall d’Hebron study adds peer-reviewed evidence that Techcyte’s AI-assisted microscopy can match conventional review closely while helping surface more candidate parasite findings for expert confirmation.